Loading…
20,252 grants found
Showing 861 – 880 of 20,252 grants
Chimeric Antigen Receptors (CARs) are a combination of an extracellular single-chain variable fragment region (scFV) that recognizes tumor protein antigens in an MHC independent ma...
Summary Cancer cells harbor signs of genomic instability, including genome rearrangements, which can contribute to tumor development. Faithful DNA repair combats this instability a...
Abstract Activating KRAS mutations occur in 20-40% of non-small cell lung cancers (NSCLCs). About 20% of the KRAS mutation tumors have co-occurring mutations of KEAP1 that are resi...
PROJECT SUMMARY / ABSTRACT Research Plan: Tumor evolution is a fundamental obstacle to cancer treatment, as malignant cells adapt to treatment and change during progression. Unders...
The ability to diagnose and classify leukemias and lymphomas (LLs), in children and young adults is limited in Kenya and most of Sub-Saharan Africa. LLs represent nearly half the c...
Ewing sarcoma (ES) is a pediatric malignancy, which carries adverse prognosis in its metastatic form. Bone metastases, although less common, associate with the worst clinical outco...
PROJECT SUMMARY Neuroblastoma (NB) is the most common extracranial solid tumor of childhood that leads to a disproportionate number of childhood cancer deaths and an even more disp...
Metastatic lung cancer kills >160,000 people in the US annually, and 10%-50% of patients with surgically resected lung cancer will develop distant metastasis. There remains an u...
Abstract The overall goal of this line of research is to examine the psychosocial, ethical, and clinical implications of incidental medical findings of clonal hematopoiesis (CH) in...
PROJECT SUMMARY Despite unprecedented clinical success of chimeric antigen receptor (CAR)-T cell therapy against tumors, widespread application is limited by lengthy and labor-inte...
PROJECT SUMMARY The immediate objective of our proposal is to increase immune density within solid malignancies to rectify defects in anti-tumor immunity and maximize response rate...
PROJECT SUMMARY Targeted nanotechnologies have shown great promise in overcoming roadblocks in cancer therapeutics. Tumor metastasis has a limited response or resistance to chemoth...
PROJECT ABSTRACT Small cell lung cancer (SCLC) and neuroendocrine prostate cancer (NEPC) are aggressive, high-grade neuroendocrine neoplasms (HG-NENs) that often metastasize and do...
PROJECT SUMMARY Colon cancer is a leading cause of cancer-related death for both men and women in the United States. Abnormal DNA methylation patterning is an epigenetic hallmark o...
PROJECT SUMMARY In November 2023, New York City (NYC), NY became the first jurisdiction in the US to adopt an added sugar warning policy, which requires restaurants to display a wa...
Project Summary Breast cancer (BC) is the most frequently diagnosed cancer in women. In addition, metastatic BC has a 5-year survival rate of only 27% and metastases are associated...
PROJECT SUMMARY/ABSTRACT Despite advances in the development of highly effective androgen receptor (AR)-directed therapies for the treatment of men with advanced prostate cancer, a...
Project Summary The 5-year survival rate for patients diagnosed with pancreatic ductal adenocarcinomas (PDACs) is 11%. This poor outcome is due to multiple factors, including rapid...
Project Summary Breast cancer is still the most common malignancy in women worldwide. Despite the incredible advances made in the past decades towards eliminating breast cancer, ne...
PROJECT SUMMARY/ABSTRACT Chimeric antigen receptor T-cells (CART) have revolutionized cancer therapy. However, CART cause two common and severe toxicities: Cytokine Release Syndrom...